Related Experiment Video
Updated: Feb 16, 2026

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach
Published on: February 21, 2019
CK2 negatively regulates Galphas signaling
Heike Rebholz1, Akinori Nishi, Sabine Liebscher
1Laboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, NY 10065, USA.
Abstract:
We present evidence, using biochemical and cellular approaches, that the kinase, CK2, negatively controls signaling via Galpha(s) (or Galpha(olf)) coupled to dopamine D1 and adenosine A2A receptors. Pharmacological inhibition of CK2 or CK2 knockdown by RNAi lead to elevated cAMP levels in dopamine D1 receptor-activated neuroblastoma cells. Phosphorylation levels of protein kinase A substrates were increased in the presence of CK2 inhibitors in mouse striatal slices. The effect of D1 receptor and A2A receptor agonists on the phosphorylation of protein kinase A sites was potentiated upon CK2 inhibition. Furthermore, in cell lines, we observed that reduction in CK2 activity, pharmacologically or genetically, reduced the amount of D1 receptor that was internalized in response to dopamine. Finally, the beta subunit of CK2 was found to interact specifically with the Galpha(s) subunit through protein interaction analyses. Thus CK2 can inhibit G protein-coupled receptor action by enabling faster receptor internalization, possibly through a direct association with Galpha(s).
Insights
The kinase CK2 (Casein Kinase 2) inhibits signaling for dopamine D1 and adenosine A2A receptors. Inhibiting CK2 boosts cAMP levels and receptor signaling, suggesting CK2 as a target for neurological disorders.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- G protein-coupled receptors (GPCRs) like dopamine D1 and adenosine A2A receptors are crucial in neurological functions.
- The kinase CK2 (Casein Kinase 2) is implicated in various cellular processes, but its role in GPCR signaling remains unclear.
Purpose of the Study:
- To investigate the role of CK2 in regulating signaling pathways associated with dopamine D1 and adenosine A2A receptors.
- To elucidate the molecular mechanisms by which CK2 influences GPCR activity and downstream signaling.
Main Methods:
- Biochemical assays to measure cAMP levels and protein phosphorylation.
- Cellular approaches including RNA interference (RNAi) for CK2 knockdown.
- Protein interaction analyses to identify direct binding partners.
- Pharmacological inhibition of CK2 activity in cell lines and mouse striatal slices.
Main Results:
- Inhibition or knockdown of CK2 increased cAMP levels in dopamine D1 receptor-activated cells.
- CK2 inhibition potentiated the effects of D1 and A2A receptor agonists on protein kinase A substrate phosphorylation.
- Reduced CK2 activity decreased D1 receptor internalization upon dopamine stimulation.
- The beta subunit of CK2 was found to directly interact with the Galpha(s) subunit.
Conclusions:
- CK2 negatively regulates signaling of Galpha(s)-coupled dopamine D1 and adenosine A2A receptors.
- CK2 may inhibit GPCR function by promoting receptor internalization, potentially via direct interaction with Galpha(s).
- These findings highlight CK2 as a potential therapeutic target for modulating dopaminergic and adenosinergic signaling in neurological conditions.
Related Concept Videos
Negative Regulator Molecules
GTPases and their Regulation
Large G-proteins,...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Bacterial Signaling
Positive, Negative, and Zero Work
What is Cell Signaling?

